Nidanilimab (Nadunolimab)

(Synonyms: CAN04; Anti-IL-1RAP/IL-1R3 Reference Antibody (nidanilimab))
Customer Review

Based on 1 Customer Validation

Nidanilimab (CAN04) is a fully humanized monoclonal anti-IL1RAP antibody with a Kd value of 1.10 pM. Nidanilimab blocks IL1α and IL1β signaling and stimulates the immune system to destroy tumour cells. Nidanilimab can be used in research of non-small lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) .

For research use only. We do not sell to patients.

  • Purity: 99.90%
  • CAS No.: 2171061-85-9
  • Molecular Weight:144.3 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00